Skip to main content
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Interleukin(IL)-1/IL-6-inhibitor-associated drug reaction with eosinophilia and systemic symptoms (DReSS) in systemic inflammatory illnesses.
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use.
Improving Access to Therapy for Patients With Inborn Errors of Immunity: A Call to Action.
Transition of Care in Inborn Errors of Immunity: Outcomes of a Single-Center Quality Improvement Initiative.
A Spot of Good News: Israeli Experience With SCID Newborn Screening.
Morbidity, Mortality, and Therapeutics in Combined Immunodeficiency: Data From the USIDNET Registry.
The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years.
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Successful SCID gene therapy in infant with disseminated BCG.